Anthem, Blue Venture Fund and Optum Ventures returned to reinvest in the in-home renal care technology developer at a $2.5bn valuation, alongside participants including Inova Health System.

US-based kidney disease care service Somatus received more than $325m on Wednesday in a series E round featuring health insurers Anthem and BlueCross BlueShield Association, prescription manager Optum and hospital operator Inova Health System.

Asset manager Wellington Management led the round, which included financial services and investment group Fidelity Management & Research as well as RA Capital Management, GIC Private, Deerfield Management, Flare Capital Partners and Longitude Capital.

Blue Venture Fund and Optum Ventures represented BlueCross BlueShield Association and Optum…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn